Skip links

Dojolvi® (triheptanoin)

Full Name Dojolvi® (triheptanoin)
Drug Dojolvi
Manufacturer Ultragenyx
Route of Administration Oral or Gastrointestinal Tube
Site of Care Home
Approved Indication The treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD)
Disease Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number 800-546-7102
Fax Number 877-389-5186
Product Website dojolvihcp.com